P23: Elvitegravir/cobicistat/emtricitabine/tenofovir DF demonstrates durable efficacy and safety versus efavirenz/emtricitabine/tenofovir DF at Week 144

2014 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []